Trial of the Use of Antenatal Corticosteroids in Developing Countries
NCT01084096 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 103117
Last updated 2024-12-09
Summary
Multi-country two-arm, parallel cluster randomized controlled trial to reduce neonatal mortality through increasing the rate of antenatal corticosteroid administration to eligible women.
Conditions
Interventions
- BEHAVIORAL
-
Increasing use of Antenatal Corticosteroids (ACS)
Intervention clusters: * Increasing administration of ACS to pregnant women at high risk of preterm birth (HRPB) by providing health providers with kits containing dexamethasone, syringes, and instructions. Eligible women receive four injections of 6 mg dexamethasone from the kit or regimen of choice at the site. * Improving identification of women at HRPB by diffusing recommendations for ACS use to health care providers, training health care providers to identify signs of preterm labor and eligibility criteria for ACS use, providing reminders to healthcare providers on the use of the kits, and using a color-coded tape to measure uterine height to estimate gestational age in women at HRPB with unknown gestational age. Control clusters: no specific intervention for comparison. Both intervention and control clusters: Birth attendants trained in essential newborn care of LBW infants and instructed to teach mothers how to provide care to premature infants.
Sponsors & Collaborators
-
RTI International
collaborator OTHER -
Tulane University School of Medicine
collaborator OTHER -
Institute for Clinical Effectiveness and Health Policy
collaborator OTHER -
University of Alabama at Birmingham
collaborator OTHER -
University Teaching Hospital, Lusaka, Zambia
collaborator OTHER -
University of Colorado, Denver
collaborator OTHER -
Universidad Francisco Marroquín
collaborator OTHER -
Jawaharlal Nehru Medical College
collaborator OTHER -
Christiana Care Health Services
collaborator OTHER -
Aga Khan University
collaborator OTHER - collaborator OTHER
-
Indiana University
collaborator OTHER -
Moi Univeristy
collaborator OTHER -
Lata Medical Research Foundation, Nagpur
collaborator OTHER -
Massachusetts General Hospital
collaborator OTHER -
NICHD Global Network for Women's and Children's Health
lead NETWORK
Principal Investigators
-
Fernando Althabe, M.D. · Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-10-31
- Primary Completion
- 2014-03-31
- Completion
- 2014-04-30
Countries
- Argentina
- Guatemala
- India
- Kenya
- Pakistan
- Zambia
Study Locations
More Related Trials
-
The Effect of Low Doses of Prednisone on the Prolongation of Pregnancy in Threatened Preterm Birth
NCT06103227 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Antenatal Corticosteroids on Neonatal Morbidity.
NCT03446937 ·Status: COMPLETED ·Phase: NA
-
Maternal and Fetal/Neonatal Pharmacokinetics and - Dynamics of Corticosteroids During Pregnancy
NCT06264973 ·Status: RECRUITING
-
Euglycemia After Antenatal Late Preterm Steroids, the E-ALPS Study
NCT03076775 ·Status: COMPLETED ·Phase: NA
-
Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)
NCT05114096 ·Status: RECRUITING ·Phase: PHASE4
-
The Effect of Antenatal Corticosteroids on the Fetal Thymus - a Possible Role in Fetal Immune Programming
NCT03057717 ·Status: COMPLETED ·Phase: NA
-
Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study (MACS)
NCT00187382 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of ACS in Twin With LPB: Study Protocol for a RCT
NCT03547791 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Dose Reduction of Antenatal Betamethasone Given to Prevent the Neonatal Complications Associated With Very Preterm Birth
NCT02897076 ·Status: COMPLETED ·Phase: PHASE3
-
Aggressive Versus Expectant Management of Severe Preeclampsia Remote From Term
NCT01164852 ·Status: COMPLETED ·Phase: NA
-
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Antenatal Thyrotropin-Releasing Hormone in Pregnant Women With Threatened Premature Delivery
NCT00004778 ·Status: COMPLETED ·Phase: PHASE3
-
Weekly Antepartum Testing in Women With BMI 30-40 and Neonatal Outcomes
NCT04180566 ·Status: TERMINATED ·Phase: NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
NCT02273297 ·Status: RECRUITING
-
A Cluster-Randomized Trial of Ultrasound Use to Improve Pregnancy Outcomes in Low Income Country Settings
NCT01990625 ·Status: COMPLETED ·Phase: NA
-
Angiogenic Factors in the Conservative Management of Gestational Hypertension
NCT06123377 ·Status: RECRUITING ·Phase: NA
-
Continuous Glucose Monitoring of Late Preterm Birth After Corticosteroids
NCT03738293 ·Status: WITHDRAWN
-
The Effect of Steroids on Maternal Glucose Levels
NCT03021837 ·Status: COMPLETED
-
The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study
NCT06517628 ·Status: RECRUITING
-
Biological Markers of Disease in the Prediction of Preterm Delivery, Preeclampsia and Intra-Uterine Growth Retardation: A Longtitudinal Study
NCT00340899 ·Status: COMPLETED
-
Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients
NCT01875107 ·Status: WITHDRAWN ·Phase: PHASE4
-
Impact of Antenatal Betamethasone on Plasma Glucose Levels
NCT00585676 ·Status: COMPLETED
-
The Effect of Antenatal Corticosteroid on Umbilical Artery Doppler Velocimetry in IUGR
NCT05588986 ·Status: COMPLETED
-
Quarenta Semanas: Innovative Intervention in Prenatal Care for Reduction of Prematurity
NCT02506725 ·Status: UNKNOWN ·Phase: NA
-
Furosemide vs. Placebo for Severe Antepartum Hypertension
NCT04615624 ·Status: COMPLETED ·Phase: PHASE3
-
Antenatal Betamethasone Compared to Dexamethasone - "BETACODE TRIAL"
NCT00418353 ·Status: COMPLETED ·Phase: NA